公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2018 | Oncological outcomes of high-risk prostate cancer patients between robot-assisted laparoscopic radical prostatectomy and laparoscopic radical prostatectomy in Taiwan | Liao C.-C.; YU-CHUAN LU ; Tai H.-C.; CHUNG-HSIN CHEN ; YEONG-SHIAU PU ; CHAO-YUAN HUANG | Urological Science | 3 | 4 | |
2015 | The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer | Wang Y.-J.; CHAO-YUAN HUANG ; Hou W.-H.; CHIA-CHUN WANG ; KENG-HSUEH LAN ; CHUNG-HSIN CHEN ; HONG-JENG YU ; Lai M.-K.; ANN-LII CHENG ; SHIH-PING LIU ; YEONG-SHIAU PU ; CHIA-HSIEN CHENG | World Journal of Surgical Oncology | 4 | 4 | |
2021 | Outcomes and Prediction Models for Exclusive Prostate Bed Salvage Radiotherapy among Patients with Biochemical Recurrence after Radical Prostatectomy | CHI-SHIN TSENG ; Wang, Yu-Jen; CHUNG-HSIN CHEN ; SHUO-MENG WANG ; KUO-HOW HUANG ; PO-MING CHOW ; YEONG-SHIAU PU ; CHAO-YUAN HUANG ; Cheng, Jason Chia-Hsien | Cancers | 4 | 4 | |
2018 | Outcomes of prostate atypical small acinar proliferation and high-grade prostate intraepithelial neoplasm patients | Tung S.-Y.; YEONG-SHIAU PU ; CHAO-YUAN HUANG ; HONG-CHIANG CHANG ; KUO-HOW HUANG ; SHUO-MENG WANG ; Tai H.-C.; CHUNG-HSIN CHEN | Urological Science | 1 | 0 | |
2022 | Outcomes of stratified transurethral resection of bladder tumor: A propensity score-matched analysis | Huang, Wei-Lun; CHAO-YUAN HUANG ; KUO-HOW HUANG ; YEONG-SHIAU PU ; HONG-CHIANG CHANG ; PO-MING CHOW | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 0 | |
2022 | Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer | Kanesvaran, R; Castro, E; Wong, A; Fizazi, K; Chua, M L K; Zhu, Y; Malhotra, H; Miura, Y; Lee, J L; Chong, F L T; YEONG-SHIAU PU ; Yen, C-C; Saad, M; Lee, H J; Kitamura, H; Prabhash, K; Zou, Q; Curigliano, G; Poon, E; Choo, S P; Peters, S; Lim, E; Yoshino, T; Pentheroudakis, G | ESMO open | 12 | 6 | |
2021 | Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma | Kanesvaran, R; Porta, C; Wong, A; Powles, T; Ng, Q S; Schmidinger, M; Ye, D; Malhotra, H; Miura, Y; Lee, J L; Chong, F L T; YEONG-SHIAU PU ; Yen, C-C; Saad, M; Lee, H J; Kitamura, H; Bhattacharyya, G S; Curigliano, G; Poon, E; Choo, S P; Peters, S; Lim, E; Yoshino, T; Pentheroudakis, G | ESMO open | 13 | 13 | |
2015 | Paragangliomas of the urinary bladder: A report of 6 cases and review of the literature | YI-KAI CHANG ; CHIANG I-NI ; CHUNG-HSIN CHEN ; SHUO-MENG WANG ; YUAN-JU LEE ; YEONG-SHIAU PU ; CHAO-YUAN HUANG | Urological Science | 4 | 0 | |
2016 | Perioperative changes in TGF-β1 levels predict the oncological outcome of cryoablation-receiving patients with localized prostate cancer | Wang A.S.-S.; CHUNG-HSIN CHEN ; Chou Y.-T.; YEONG-SHIAU PU | Cryobiology | 4 | 4 | |
2001 | Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions | ANN-LII CHENG ; CHIH-HUNG HSU ; Lin J.-K.; Hsu M.-M.; YUNN-FANG HO ; She T.-S.; JENG-YUH KO ; Lin J.-T.; BOR-RU LIN ; MING-SHIANG WU ; Yu H.-S.; SHIOU-HWA JEE ; Chen G.-S.; Chen T.-M.; CHI-AN CHEN ; Lai M.-K.; YEONG-SHIAU PU ; MIN-HSIUNG PAN ; Wang Y.-J.; Tsai C.-C.; CHANG-YAO HSIEH | Anticancer Research | 1925 | 1695 | |
1997 | Phase II Clinical Trial of Monthly Triptorelin Injection for Prostate Cancer | YEONG-SHIAU PU ; Jun Chen; Ming-Kuen Lai; Kuei-Li Wu; Yi-Jiun Jou; Teh-Sheng Hsieh; Tsong-Chang Tsai | 中華民國泌尿科醫學會雜誌 | | 0 | |
2007 | Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma | CHIA-CHI LIN ; CHIH-HUNG HSU ; CHAO-YUAN HUANG ; ANN-LII CHENG ; Vogelzang N.J.; YEONG-SHIAU PU | Journal of Urology | 20 | 18 | |
2009 | Phloroglucinols Inhibit Chemical Mediators and Xanthine Oxidase, and Protect Cisplatin-Induced Cell Death by Reducing Reactive Oxygen Species in Normal Human Urothelial and Bladder Cancer Cells | Lin K.-W.; Huang A.-M.; Tu H.-Y.; Weng J.-R.U.; Hour T.-C.; Wei B.-L.; Yang S.-C.; Wang J.-P.; YEONG-SHIAU PU ; Lin C.-N. | Journal of Agricultural and Food Chemistry | 11 | 11 | |
2001 | A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer | CHIA-CHI LIN ; CHIH-HUNG HSU ; Chen J.; Tsai T.-C.; ANN-LII CHENG ; YEONG-SHIAU PU | Anticancer Research | 14 | 13 | |
2008 | Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility | Huang Y.-K.; YEONG-SHIAU PU ; Chung C.-J.; Shiue H.-S.; Yang M.-H.; Chen C.-J.; Hsueh Y.-M. | Food and Chemical Toxicology | 54 | 45 | |
2012 | Pneumopelvis, pneumoureter and pneumobladder | Weng W.-C.; YEONG-SHIAU PU ; HONG-JENG YU ; CHAO-YUAN HUANG | QJM | 0 | 1 | |
2010 | Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7 | Hsu Y.-H.; Lin W.-L.; Hou Y.-T.; YEONG-SHIAU PU ; CHIA-TUNG SHUN ; CHI-LING CHEN ; Wu Y.-Y.; Chen J.-Y.; Chen T.-H.; TZUU-SHUH JOU | American Journal of Pathology | 73 | 69 | |
2013 | Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma | Wu C.-C.; Huang Y.-K.; Chung C.-J.; CHAO-YUAN HUANG ; YEONG-SHIAU PU ; Shiue H.-S.; Lai L.-A.; Lin Y.-C.; Su C.-T.; Hsueh Y.-M. | Toxicology and Applied Pharmacology | 30 | 24 | |
2020 | Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma | Chung C.-J.; Bao B.-Y.; Lin Y.-C.; Huang Y.-L.; Shiue H.-S.; Ao P.-L.; YEONG-SHIAU PU ; CHAO-YUAN HUANG ; Hsueh Y.-M. | Scientific Reports | 10 | 7 | |
2017 | The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma | Hsueh Y.-M.; Lin Y.-C.; Chen W.-J.; CHAO-YUAN HUANG ; Shiue H.-S.; YEONG-SHIAU PU ; Chen C.-H.; Su C.-T. | Toxicology and Applied Pharmacology | 9 | 10 | |